Samarth Kulkarni - 02 Jun 2025 Form 4 Insider Report for Oruka Therapeutics, Inc. (ORKA)

Role
Director
Signature
/s/ Paul Quinlan, as attorney-in-fact for Samarth Kulkarni
Issuer symbol
ORKA
Transactions as of
02 Jun 2025
Net transactions value
$0
Form type
4
Filing time
03 Jun 2025, 16:14:17 UTC
Previous filing
24 Mar 2025
Next filing
12 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kulkarni Samarth Director C/O ORUKA THERAPEUTICS, INC., 855 OAK GROVE AVE., SUITE 100, MENLO PARK /s/ Paul Quinlan, as attorney-in-fact for Samarth Kulkarni 03 Jun 2025 0001682019

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORKA Stock Option (right to buy) Award $0 +17,500 $0.000000 17,500 02 Jun 2025 Common Stock 17,500 $11.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/12 of the underlying shares monthly from June 2, 2025.